Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients

American Journal of Hematology

Volumn 85, Issue 4, 2010, Pages 288-290

  Taher, Ali T ^a   Musallam, Khaled M ^a   Wood, John C ^b   Cappellini, Maria Domenica ^c  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; FEMALE; FERRITIN BLOOD LEVEL; HEART MUSCLE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON CHELATION; IRON OVERLOAD; LIVER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THALASSEMIA; THALASSEMIA INTERMEDIA; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; ANEMIA; BETA-THALASSEMIA; BLOOD TRANSFUSION; FEMALE; FERRITINS; HUMANS; IRON; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MYOCARDIUM; ORGAN SPECIFICITY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77950377763     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21626     Document Type: Article

References (22)

1. Taher A, Ismaeel H, Cappellini MD. Thalassaemia intermedia: Revisited. Blood Cells Mol Dis 2006;37:12-20.
2. Kleber FX, Niemoller L, Doering W. Impact of converting enzyme inhibition on progression of chronic heart failure: Results of the Munich mild heart failure trial. Br Heart J 1992;67:289-296.
3. St Pierre TG, Clark PR, Chua-anusorn W. Measurement and mapping of liver iron concentrations using magnetic resonance imaging. Ann N Y Acad Sci 2005;1054:379-385. (Pubitemid 43031045)
4. Wood JC. Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol 2007;14:183-190. (Pubitemid 46597601)
5. Origa R, Galanello R, Ganz T, et al. Liver iron concentrations and urinary hepcidin in b-thalassemia. Haematologica 2007;92:583-588. (Pubitemid 350144260)
6. Taher A, El RF, Isma'eel H, et al. Correlation of liver iron concentration determined by R2 MRI with serum ferritin in patients with thalassemia intermedia. Haematologica 2008;93:1584-1585.
7. Pakbaz Z, Fischer R, Fung E, et al. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer 2007;49:329-332. (Pubitemid 47236225)
8. Kearney SL, Nemeth E, Neufeld EJ, et al. Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer 2007;48:57-63.
9. Kattamis A, Papassotiriou I, Palaiologou D, et al. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica 2006;91:809-812. (Pubitemid 44014549)
10. Origa R, Barella S, Argiolas GM, et al. No evidence of cardiac iron in 20 never or minimally transfused patients with thalassemia intermedia. Haematologica 2008;93:1095-1096.
11. Chirnomas SD, Geukes-Foppen M, Barry K, et al. Practical implications of liver and heart iron load assessment by T2*-MRI in children and adults with transfusion-dependent anemias. Am J Hematol 2008;83:781-783.
12. Mavrogeni S, Gotsis E, Ladis V, et al. Magnetic resonance evaluation of liver and myocardial iron deposition in thalassemia intermedia and b-thalassemia major. Int J Cardiovasc Imaging 2008;24:849-854.
13. Voskaridou E, Douskou M, Terpos E, et al. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol 2004;126:736-742. (Pubitemid 39221312)
14. Au WY, Lam WWM, Chu WWC, et al. Organ-specific hemosiderosis and functional correlation in Chinese patients with thalassemia intermedia and hemoglobin H disease. Ann Hematol 2009;88:947-950.
15. Lombardo T, Tamburino C, Bartoloni G, et al. Cardiac iron overload in thalassemic patients: An endomyocardial biopsy study. Ann Hematol 1995;71:135-141.
16. Sonakul D, Thakerngpol K, Pacharee P. Cardiac pathology in 76 thalassemic patients. Birth Defects Orig Artic Ser 1988;23:177-191.
17. Link G, Pinson A, Hershko C. Heart cells in culture: A model of myocardial iron overload and chelation. J Lab Clin Med 1985;106:147-153.
18. Nathan DG. Thalassemia: The continued challenge. Ann N Y Acad Sci 2005; 1054:1-10.
19. Wood JC. Cardiac iron across different transfusion-dependent diseases. Blood Rev 2008;22:S14-S21.
20. Noetzli LJ, Carson SM, Nord AS, et al. Longitudinal analysis of heart and liver iron in thalassemia major. Blood 2008;112:2973-2978.
21. Wood JC, Tyszka JM, Carson S, et al. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 2004;103:1934-1936. (Pubitemid 38268994)
22. Jensen PD, Jensen FT, Christensen T, et al. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: Indication of close relation between myocardial iron content and chelatable iron pool. Blood 2003;101:4632-4639. (Pubitemid 36857840)